Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04767464 · ClinicalTrials.gov registry record · NA

Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups

A NA study of Breast Cancer and Breast Neoplasm, sponsored by Mary Radomski.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04767464: Completed NA study of Breast Cancer and Breast Neoplasm, sponsored by Mary Radomski.

NCT04767464 is a NA study of Breast Cancer and Breast Neoplasm that has completed, run by Mary Radomski. The registered enrollment target is 20 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04767464, a NA study of Breast Cancer and Breast Neoplasm, has completed, sponsored by Mary Radomski.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The Compass Course (CC) is a group intervention designed for individuals with Breast Cancer. Over the course of 8 face-to-face group sessions, the CC is designed to help participants reclaim a sense of self-grounded purpose in daily life, defined as intentional use of time and energy in ways that align with one's values, strengths, and sources of personal meaning (e.g., inner compass) in the moments that compose a day. Because of COVID-19, in-person groups are discouraged and so we need to identify new ways to provide group-based interventions that are feasible and efficacious.

Interventions

  • OTHER Compass Course

Study Locations (1)

Minnesota

  • Abbott Northwestern Hospital - Minneapolis

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-03-01
Est. Completion 2023-11-07
Phase NA

Sponsor

Mary Radomski

2 total trials

What the Registry Record Tells You About NCT04767464

The ClinicalTrials.gov registry entry for NCT04767464 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Mary Radomski, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Compass Course is the first listed.

NCT04767464 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04767464 about?

NCT04767464 is a clinical study titled "Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups". The Compass Course (CC) is a group intervention designed for individuals with Breast Cancer. Over the course of 8 face-to-face group sessions, the CC is designed to help participants reclaim a sense of self-grounded purpose in daily life, defined as intentional use of time and energy in ways that al...

What is the current status of trial NCT04767464?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-03-01. Estimated completion is 2023-11-07.

What conditions does trial NCT04767464 study?

This clinical trial studies the following conditions: Breast Cancer, Breast Neoplasm.

What interventions are being tested in trial NCT04767464?

The interventions under investigation include: Compass Course (OTHER).

Who is sponsoring clinical trial NCT04767464?

This trial is sponsored by Mary Radomski, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04767464 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.